Send us Feedback

Vascular Solutions (VASC)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

 
Annual Reports

 
Quarterly Reports

 
8-K

  • 8-K (May 7, 2013)
  • 8-K (Apr 23, 2013)
  • 8-K (Feb 5, 2013)
  • 8-K (Dec 7, 2012)
  • 8-K (Dec 4, 2012)
  • 8-K (Oct 29, 2012)

 
Other

Vascular Solutions 8-K 2012

Documents found in this filing:

  1. 8-K
  2. 8-K
form8k.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
Date of Report: May 4, 2012
 
(date of earliest event reported)
 
 VASCULAR SOLUTIONS, INC.
(Exact name of registrant as specified in its charter)
 
Commission File Number: 0-27605
 
 
Minnesota
  
41-1859679
(State or other jurisdiction of incorporation)
  
(IRS Employer Identification No.)
 
6464 Sycamore Court
Minneapolis, Minnesota 55369
(Address of principal executive offices)
 
 (763) 656-4300
(Registrant’s telephone number, including are code)
 
 Not Applicable
(Former name or former address, if changed since last report)
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o
Written communications pursuant to Rule 425 under Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act ( 17 CFR 240.13e-4(c))
 
 
 
 
 
Item 5.07. 
Submission of Matters to a Vote of Security Holders.
 
At the Annual Meeting held on May 4, 2012, the Company’s shareholders approved each of the following proposals, which were set forth in the Proxy Statement for the 2012 Annual Meeting of Shareholders:
 
Proposal 1
 
 The Company’s shareholders elected each of the seven director nominees to a one-year term and until the director’s successor is elected and qualified (except in the case of earlier death, resignation or removal) as follows:
 
   
FOR
    
WITHHOLD
    
BROKER NON-VOTE
  
                   
John Erb
     9,363,697       214,031       5,723,496  
Michael Kopp
     9,290,318       287,410       5,723,496  
Richard Nigon
     9,369,747       207,981       5,723,496  
Paul O’Connell
     9,435,336       142,392       5,723,496  
Howard Root
     9,363,623       214,105       5,723,496  
Jorge Saucedo
     9,442,942       134,786       5,723,496  
Martin Emerson
     9,365,860       211,868       5,723,496  
 
Proposal 2
 
The Company’s shareholders ratified the appointment of Baker Tilly Virchow Krause, LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2012:
 
FOR
AGAINST
ABSTAIN
BROKER NON-VOTE
       
15,136,357 151,569 13,298 0

 
 
 
 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
VASCULAR SOLUTIONS, INC.
       
Date:  May 8, 2012
By:
/s/ James Hennen
  
   
James Hennen
  
       
   
Its: Chief Financial Officer
 
 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki